[go: up one dir, main page]

DK0927037T3 - Aerosolformuleringer af mometason-furoat uden chlorfluorcarbonhydrider - Google Patents

Aerosolformuleringer af mometason-furoat uden chlorfluorcarbonhydrider

Info

Publication number
DK0927037T3
DK0927037T3 DK97940582T DK97940582T DK0927037T3 DK 0927037 T3 DK0927037 T3 DK 0927037T3 DK 97940582 T DK97940582 T DK 97940582T DK 97940582 T DK97940582 T DK 97940582T DK 0927037 T3 DK0927037 T3 DK 0927037T3
Authority
DK
Denmark
Prior art keywords
chlorofluorocarbons
mometasone furoate
aerosol formulations
aerosol
formulations
Prior art date
Application number
DK97940582T
Other languages
Danish (da)
English (en)
Inventor
Julianne Berry
Joel A Sequeira
Imtiaz A Chaudry
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK0927037T3 publication Critical patent/DK0927037T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • A61K9/124Aerosols; Foams characterised by the propellant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
DK97940582T 1996-08-29 1997-08-26 Aerosolformuleringer af mometason-furoat uden chlorfluorcarbonhydrider DK0927037T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70536896A 1996-08-29 1996-08-29
PCT/US1997/014708 WO1998008519A1 (fr) 1996-08-29 1997-08-26 Formulations pour mometazone furoate aerosol sans cfc

Publications (1)

Publication Number Publication Date
DK0927037T3 true DK0927037T3 (da) 2001-09-24

Family

ID=24833161

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97940582T DK0927037T3 (da) 1996-08-29 1997-08-26 Aerosolformuleringer af mometason-furoat uden chlorfluorcarbonhydrider

Country Status (30)

Country Link
EP (1) EP0927037B1 (fr)
JP (1) JP3264496B2 (fr)
KR (1) KR100316358B1 (fr)
CN (1) CN1162157C (fr)
AR (1) AR008309A1 (fr)
AT (1) ATE202936T1 (fr)
AU (1) AU719079B2 (fr)
BR (1) BR9711445A (fr)
CA (1) CA2263905C (fr)
CO (1) CO4900027A1 (fr)
CZ (1) CZ294064B6 (fr)
DE (1) DE69705628T2 (fr)
DK (1) DK0927037T3 (fr)
ES (1) ES2159148T3 (fr)
GR (1) GR3036674T3 (fr)
HU (1) HU227915B1 (fr)
ID (1) ID18137A (fr)
IL (1) IL128714A (fr)
MY (1) MY117377A (fr)
NO (1) NO322528B1 (fr)
NZ (1) NZ334112A (fr)
PE (1) PE100198A1 (fr)
PL (1) PL189036B1 (fr)
PT (1) PT927037E (fr)
SA (1) SA97180339B1 (fr)
SK (1) SK282147B6 (fr)
TR (1) TR199900379T2 (fr)
TW (1) TW475901B (fr)
WO (1) WO1998008519A1 (fr)
ZA (1) ZA977668B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874481A (en) * 1995-06-07 1999-02-23 Alliance Pharmaceutical Corp. Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
CA2382133C (fr) 2000-05-10 2010-11-23 Alliance Pharmaceutical Corporation Poudres a base de phospholipides permettant de distribuer un medicament
AR036358A1 (es) * 2001-08-28 2004-09-01 Schering Corp Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma
EP1458360B1 (fr) 2001-12-19 2011-05-11 Novartis AG Administration pulmonaire d'aminoglycosides
GB0207906D0 (en) 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
WO2004018025A1 (fr) * 2002-08-23 2004-03-04 Schering Corporation Compositions pharmaceutiques
CA2495875C (fr) * 2002-08-27 2010-06-22 Schering Corporation Procede de production de preparations pour aerosols-doseurs
JP2007509147A (ja) * 2003-10-20 2007-04-12 シェーリング コーポレイション 薬学的エアロゾル組成物
EP1925293A3 (fr) * 2003-10-20 2010-01-13 Schering Corporation Compositions d'aérosol pharmaceutique
KR20100004993A (ko) * 2007-02-09 2010-01-13 쉐링 코포레이션 안정한 약제학적 약물 에어로졸
CN107951893B (zh) * 2016-10-18 2022-04-26 天津金耀集团有限公司 一种糠酸莫米松粉吸入剂组合物
CN107961217B (zh) * 2016-10-18 2021-06-29 天津金耀集团有限公司 一种糠酸莫米松气雾剂组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439670A (en) * 1989-11-28 1995-08-08 Riker Laboratories, Inc. Medicinal aerosol formulations
EP1277467B1 (fr) * 1991-06-10 2006-09-20 Schering Corporation Formulations d' aérosols sans chlorofluorohydrocarbures
SK140493A3 (en) * 1991-06-10 1994-10-05 Schering Corp Non-chlorofluorocarbon aerosol formulations
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias

Also Published As

Publication number Publication date
CN1233960A (zh) 1999-11-03
WO1998008519A1 (fr) 1998-03-05
NO990956D0 (no) 1999-02-26
CZ63299A3 (cs) 1999-07-14
IL128714A0 (en) 2000-01-31
HUP9902675A3 (en) 2000-02-28
JP2000503673A (ja) 2000-03-28
NO990956L (no) 1999-04-28
CN1162157C (zh) 2004-08-18
SK282147B6 (sk) 2001-11-06
SA97180339B1 (ar) 2006-01-31
BR9711445A (pt) 1999-08-24
KR20000035879A (ko) 2000-06-26
PT927037E (pt) 2001-10-31
HU227915B1 (en) 2012-05-29
JP3264496B2 (ja) 2002-03-11
PL331828A1 (en) 1999-08-02
NZ334112A (en) 2000-07-28
NO322528B1 (no) 2006-10-16
PE100198A1 (es) 1999-01-11
AU4232997A (en) 1998-03-19
IL128714A (en) 2003-05-29
HK1018206A1 (en) 1999-12-17
EP0927037B1 (fr) 2001-07-11
ATE202936T1 (de) 2001-07-15
KR100316358B1 (ko) 2001-12-12
TR199900379T2 (xx) 1999-05-21
EP0927037A1 (fr) 1999-07-07
ID18137A (id) 1998-03-05
AU719079B2 (en) 2000-05-04
DE69705628T2 (de) 2002-05-08
PL189036B1 (pl) 2005-06-30
GR3036674T3 (en) 2001-12-31
AR008309A1 (es) 1999-12-29
SK25399A3 (en) 1999-12-10
TW475901B (en) 2002-02-11
CO4900027A1 (es) 2000-03-27
CA2263905C (fr) 2002-05-14
HUP9902675A2 (hu) 2000-01-28
ES2159148T3 (es) 2001-09-16
DE69705628D1 (de) 2001-08-16
CA2263905A1 (fr) 1998-03-05
CZ294064B6 (cs) 2004-09-15
ZA977668B (en) 1998-02-26
MY117377A (en) 2004-06-30

Similar Documents

Publication Publication Date Title
DK0927037T3 (da) Aerosolformuleringer af mometason-furoat uden chlorfluorcarbonhydrider
ATE236617T1 (de) Aerosol-arzneiformulierungen
IT1293803B1 (it) Formulazioni di aerosol medicinali
NO991407D0 (no) Legemiddelaerosolformuleringer som omfatter budesonid
DK1073417T3 (da) Farmaceutisk aerosolformulering
DK0934057T3 (da) Medicinske aerosolformuleringer med formoterol
FI945524L (fi) Aerosolilääkekoostumuksia
DK0625046T3 (da) Farmaceutiske aerosolformuleringer indeholdende beclomethasondipropionat
FI935463A7 (fi) Kloorifluorihiilettömät aerosoliformulaatiot
ATE245969T1 (de) Stabile glasartige pulverformulierungen
DK0673240T3 (da) Stabiliserede medicinske aerosolopløsningsformuleringer
PT998272E (pt) Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol
NO20004540L (no) Sammensetninger av peptider, formuleringer og anvendelse derav
IT1289581B1 (it) Miscela,composizione per la protezione delle piante contenente la miscela e suo impiego
PT1014927E (pt) Utilizacao de shogaois e de gingerois para a preparacao de composicoes desodorizantes
NO985341D0 (no) Formulering omfattende mikropartikler for inhalering
ITMI941169A0 (it) Formulazioni farmaceutiche
SE9404469D0 (sv) Aerosol formulations
HUP0001536A3 (en) Sulfonamide and carboxamide derivatives and pharmaceutical compositions containing the same as the active ingredient
NO961025D0 (no) Skumformulering av oljer
ITMI920660A0 (it) Nuovo derivato di l-verbenone e composizioni farmaceutiche che lo contengono